United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2000 NY Rulings > NY F85964 - NY F86013 > NY F85989

Previous Ruling Next Ruling
NY F85989

April 25, 2000

CLA-2-29:RR:NC:2:238 F85989


TARIFF NO.: 2918.90.3000

Mr. Joseph J. Chivini
Austin Chemical Company, Inc.
1565 Barclay Boulevard
Buffalo Grove, IL 60089

RE: The tariff classification of Naproxen (CAS-22204-53-1), imported in bulk form, from India

Dear Mr. Chivini:

In your letter dated April 7, 2000, you requested a tariff classification ruling.

The subject product, Naproxen, is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic properties. It is indicated for the management of acute painful conditions such as rheumatoid arthritis, osteoarthritis, juvenile arthritis, ankylosing spondylitis, tendonitis and bursitis, and acute gout.

The applicable subheading for Naproxen, imported in bulk form, will be 2918.90.3000, Harmonized Tariff Schedule of the United States (HTS), which provides for "[C]arboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulfonated, nitrated or nitrosated derivatives: Other: Aromatic: Other: Drugs." Pursuant to General Note 13, HTS, the rate of duty will be free.

This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 212-637-7068.


Robert B. Swierupski

Previous Ruling Next Ruling

See also: